RhoA inhibits apoptosis and increases proliferation of cultured SPCA1 lung cancer cells

Dabei Liu1, Xingke Mei1, Linlin Wang1

  • 1Department of Thoracic Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110032, P.R. China.

Insights

Ras homolog family member A (RhoA) knockdown inhibits lung cancer cell proliferation and promotes apoptosis. This occurs through caspase-3 activation and reduced phospho-STAT3 signaling in SPCA1 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Rho kinase pathway is implicated in lung cancer progression.
  • Molecular mechanisms linking RhoA to lung cancer cell behavior remain unclear.

Purpose of the Study:

  • To investigate the effects of Ras homolog family member A (RhoA) on SPCA1 lung carcinoma cell proliferation and apoptosis.
  • To elucidate the underlying molecular mechanisms of RhoA's action in lung cancer.

Main Methods:

  • Small interfering RNA (siRNA) was used to silence RhoA expression in SPCA1 cells.
  • Cell proliferation was assessed using the MTS tetrazolium assay.
  • Apoptosis was quantified via flow cytometry.
  • Western blotting was employed to analyze caspase-3 and phospho-STAT3 levels.

Main Results:

  • RhoA knockdown significantly decreased SPCA1 cell proliferation.
  • RhoA inhibition led to a significant increase in SPCA1 cell apoptosis (P<0.01).
  • Molecular analysis revealed significant activation of caspase-3 and reduction of phospho-STAT3 in RhoA-silenced cells (P<0.01).

Conclusions:

  • RhoA knockdown effectively inhibits proliferation and induces apoptosis in SPCA1 lung cancer cells.
  • The observed effects are associated with caspase-3 activation and decreased phospho-STAT3 levels.
  • RhoA represents a potential therapeutic target for lung cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K